Health Press Release – Newsletter for December 15, 2010

Ocean Nutrition Canada Limited Announces Strategic Alliance with Wilmar International Limited – the World’s Largest Omega-3 EPA/DHA Food Company

Makers of Arawana Brand Cooking oil Bring a Healthier Product to Their Consumers

DARTMOUTH, Canada, December 14, 2010 – Ocean Nutrition Canada Limited (ONC), the
world's largest Omega-3 EPA/DHA solutions provider, and supplier of MEG-3(R)
brand Omega-3 EPA/DHA (eicosapentaenoic acid/docosahexaenoic acid)
ingredients, is pleased to announce that it has entered into an exclusive
long term strategic agreement with Wilmar … Original source on Gaea Times at : Ocean Nutrition Canada Limited Announces Strategic Alliance with Wilmar International Limited – the World's Largest Omega-3 EPA/DHA Food Company.

SulAmerica Enters into Contract to Acquire Dental PLAN

The acquisition will increase dental care portfolio by more than 30%
SAO PAULO, December 14, 2010 – SulAmerica (BM&FBovespa: SULA11) announced today the signing of a share
purchase agreement for the acquisition of Dental PLAN Ltda., one of the major
dental care providers in the North and Northeast regions of Brazil, which has
also shown a significant growth …. Source article on Gaea Times at  : SulAmerica Enters into Contract to Acquire Dental PLAN.

3D Keyhole Surgery at the Forefront of Cutting-edge Research

GUILDFORD, England, December 14, 2010 – Doctors will shortly be performing the world's first remote 3D keyhole
surgery during a symposium at the University of Surrey. Keyhole surgery -
where doctors operate on organs through a tiny incision – reduces the length
of hospital stays and post-operative complications. This also means that
patients experience less scarring and pain. … Read more >>.

Italy’s National Agency for Regional Health Services (Agenas) Names Zimmer(R) NexGen(R) LPS Knee the Most Cost-Effective Total Knee Replacement Implant

WINTERTHUR, Switzerland, December 14, 2010 – Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a leader in musculoskeletal
care, today announced that the Zimmer NexGen LPS knee was ranked the most
cost-effective multiradius design total knee replacement implant in Italy in
a recent health technology assessment by Italy's National Agency for Regional
Health Services.(1)

The assessment … Read the original article on Gaea Times at : Italy's National Agency for Regional Health Services (Agenas) Names Zimmer(R) NexGen(R) LPS Knee the Most Cost-Effective Total Knee Replacement Implant.

Cell Biosciences Announces US Patent Issuance

SANTA CLARA, California, December 14, 2010 – Cell Biosciences, Inc. today announced the issuance of Patent No.
7,846,676 for "Methods and Devices for Analyte Detection" by the United
States Patent and Trademark Office.

The patent represents a key element of intellectual property related to
NanoPro assay technology. It is one of several within a … Read : Cell Biosciences Announces US Patent Issuance.

Elsevier Launches Executable Paper Grand Challenge

Contest Created to Improve the way Scientific Information is Communicated and Used

NEW YORK, December 14, 2010 – Elsevier, a leading global publisher of scientific, technical and medical
information, announced today that it has launched a new competition that
invites scientists to improve how data intensive research is represented in a
scholarly journal article. The Elsevier Executable Paper …. Original source  : Elsevier Launches Executable Paper Grand Challenge.

Amira Pharmaceuticals to Present Preclinical, Clinical Data from DP2 Receptor Antagonist Program at Pacifichem 2010

SAN DIEGO, December 14, 2010 – Amira Pharmaceuticals, Inc. announced today that it will present
preclinical and clinical data from its DP2 receptor antagonist program on
December 17, 2010, at Pacifichem 2010 in Honolulu, Hawaii. The data from
Amira's clinical-stage DP2 program will be delivered by Brian Stearns, Ph.D.,
in a presentation titled "Discovery and optimization of a …. Read the original article  : Amira Pharmaceuticals to Present Preclinical, Clinical Data from DP2 Receptor Antagonist Program at Pacifichem 2010.